Psoriatic-Arthritis

Itching can be relieved by the easily available Z and Z OTC medication combination.

Research suggests that individuals with psoriasis are at increased cancer risk and this may be associated with treatment

theRAConnection Survey Results Suggest Majority of Patients Don’t Discuss Treat to Target Goals With Their Physician

What natural or alternatives treatments have others used that have helped?

More and more of us are spending increasing hours in front of computers...

A leading doctor outlines the role of exercise in managing AS, RA, PsA, SLE and other inflammatory conditions.

Useful tips on successful pregnancy by individuals with psoriatic disease

Traveling with RA, PsA and other inflammatory conditions can be stressful - make sure you are prepared.

Stress may play a role in inflammation that causes pain - learn about Tai Chi, Relaxation, and other coping techniques.

The adrenal gland, situated just above the kidneys, produces a number of hormones that are essential for normal body...

Newer biologic medications are giving patients more effective methods of reducing symptoms of psoriasis.

Drug Payment Assistance Programs for Rheumatoid & Psoriatic Arthritis

An overview of the types of medications used to treat Psoriatic Arthritis: DMARDS to NSAIDS

National Psoriasis Foundation has released dietary recommendations for psoriasis and psoriatic arthritis.

Understand the symptoms and signs of psoriatic arthritis and how the condition is diagnosed

Discussion of how psoriatic disease affects women physically and emotionally in all aspects of work and life.

The JAK inhibitor Rinvoq represents a new treatment option for Psoriatic Arthritis

New study suggests Enbrel alone more effective than MTX or combination.

FDA approves third IL-23 inhibitor for treatment of plaque psoriasis.

Simponi®(golimumab)is one of five marketed TNF inhibitors(TNFi) that is FDA approved for use in psoriatic arthritis(PsA)

Doctors evaluated mobility, self-care, and activities of daily living in Cosentyx treated patients.

Study demonstrates that Taltz IL-17 inhibition improves psoriatic arthritis associated ethesitis and dactylitis.

Dual Inhibition of IL-17 appears promising for treatment of PsA according to University of Rochester led clinical trial

ACR recommends TNF biologic and "treat to target" approach for all individuals with Psoriatic Arthritis.

Research suggests filgotinib can benefit psoriatic arthritis patients with difficult to control disease.

Researchers provide updates on Cosentyx, Tremfya, Otezla, Filgotinib, and Taltz treatment for Psoriatic Arthritis

Cancer patients treated with checkpoint inhibitors need to bring symptoms of joint pain to their doctors attention.

Doctors from the UK report on the increased risk of infection with Remicade in the British Journal of Dermatology

Cimzia provides women with autoimmune inflammatory disease the option to control disease during pregnancy

Understand the administration, side effects and answers to frequently asked questions about Taltz® (Ixekizumab).

The U.S. Food and Drug Administration (FDA) has approved ORENCIA (abatacept) for the treatment of adults with active PsA

New research shows psoriasis increases risk of bone fractures.

Better Outcomes with Intensive Treatment in Psoriatic Arthritis

Taltz® Approved for the Treatment of Psoriasis

Spine Community News:

Cosentyx Highly Effective for Treatment of Scalp Psoriasis